Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Articles
Inhibition of Polysome Assembly Enhances Imatinib Activity against Chronic Myelogenous Leukemia and Overcomes Imatinib Resistance
Min Zhang, Wuxia Fu, Sharmila Prabhu, James C. Moore, Je Ko, Jung Woo Kim, Brian J. Druker, Valerie Trapp, John Fruehauf, Hermann Gram, Hung Y. Fan, S. Tiong Ong
Articles
The Forkhead Transcription Factor FOXO3a Increases Phosphoinositide-3 Kinase/Akt Activity in Drug-Resistant Leukemic Cells through Induction of PIK3CA Expression
Rosaline C.-Y. Hui, Ana R. Gomes, Demetra Constantinidou, Joana R. Costa, Christina T. Karadedou, Silvia Fernandez de Mattos, Matthias P. Wymann, Jan J. Brosens, Almut Schulze, Eric W.-F. Lam
CELL GROWTH AND DEVELOPMENT
hnRNP A1 Nucleocytoplasmic Shuttling Activity Is Required for Normal Myelopoiesis and BCR/ABL Leukemogenesis
Angela Iervolino, Giorgia Santilli, Rossana Trotta, Clara Guerzoni, Vincenzo Cesi, Anna Bergamaschi, Carlo Gambacorti-Passerini, Bruno Calabretta, Danilo Perrotti
CELL GROWTH AND DEVELOPMENT
Expression of Interferon Consensus Sequence Binding Protein (ICSBP) Is Downregulated in Bcr-Abl-Induced Murine Chronic Myelogenous Leukemia-Like Disease, and Forced Coexpression of ICSBP Inhibits Bcr-Abl-Induced Myeloproliferative Disorder
Sheryl X. Hao, Ruibao Ren
CELL GROWTH AND DEVELOPMENT
Bcr-Abl with an SH3 Deletion Retains the Ability To Induce a Myeloproliferative Disease in Mice, yet c-Abl Activated by an SH3 Deletion Induces Only Lymphoid Malignancy
Alec W. Gross, Xiaowu Zhang, Ruibao Ren
CELL GROWTH AND DEVELOPMENT
Protein Tyrosine Phosphatase 1B Antagonizes Signalling by Oncoprotein Tyrosine Kinase p210 bcr-abl In Vivo
Kenneth R. LaMontagne, Andrew J. Flint, B. Robert Franza, Ann Marie Pendergast, Nicholas K. Tonks